E-LIB Suche - Ergebnisse für: Kreuzer, Karl-A.

1

No recovery of T-cell receptor excision circles (TRECs) aft..:

Przybylski, Grzegorz K. ; Kreuzer, Karl-A. ; Siegert, Wolfgang.
Journal of Applied Genetics. 48 (2007) 4 - p. 397-404 , 2007

Link: https://doi.org/10.1007/..

2

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBIN..:

Yosifov, Deyan ; von Tresckow, Julia ; Giza, Adam...
HemaSphere. 7 (2023) S3 - p. e14818fb , 2023

Link: https://doi.org/10.1097/..

3

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRO..:

Al-Sawaf, Othman ; Robrecht, Sandra ; Zhang, Can...
HemaSphere. 7 (2023) S3 - p. e064430a , 2023

Link: https://doi.org/10.1097/..

4

Tislelizumab plus zanubrutinib for Richter transformation: ..:

Al-Sawaf, Othman ; Ligtvoet, Rudy ; Robrecht, Sandra...
Nature Medicine. 30 (2023) 1 - p. 240-248 , 2023

Link: https://doi.org/10.1038/..

5

General condition and comorbidity of long-term survivors of..:

Gökbuget, Nicola ; Ihrig, Kristina ; Stadler, Michael...
Haematologica. 108 (2023) 7 - p. 1758-1767 , 2023

Link: https://doi.org/10.3324/..

6

Transcriptomic profiles and 5-year results from the randomi..:

Al-Sawaf, Othman ; Zhang, Can ; Jin, Hyun Yong...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

The proto-oncogene TCL1A deregulates cell cycle and genomic..:

Stachelscheid, Johanna ; Jiang, Qu ; Aszyk, Christoph...
Blood. 141 (2023) 12 - p. 1425-1441 , 2023

Link: https://doi.org/10.1182/..

8

P586: POTENTIAL DRUG-DRUG INTERACTIONS OF ANTIFUNGAL PROPHY..:

Joisten, Carolin ; Müller, Carsten ; Mellinghoff, Sibylle...
HemaSphere. 7 (2023) S3 - p. e454364d , 2023

Link: https://doi.org/10.1097/..

9

Leukozytose:

Kreuzer, Karl-Anton
DMW - Deutsche Medizinische Wochenschrift. 148 (2023) 20 - p. 1322-1326 , 2023

Link: https://doi.org/10.1055/..

10

P630: SAFETY AND TREATMENT ADHERENCE WITH ACALABRUTINIB IN ..:

Simon, Florian ; Ligtvoet, Rudy ; Noesslinger, Thomas...
HemaSphere. 7 (2023) S3 - p. e3844763 , 2023

Link: https://doi.org/10.1097/..

11

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATI..:

Langerbeins, Petra ; Robrecht, Sandra ; Nieper, Pascal...
HemaSphere. 7 (2023) S3 - p. e9488123 , 2023

Link: https://doi.org/10.1097/..

12

Author Correction: Transcriptomic profiles and 5-year resul..:

Al-Sawaf, Othman ; Zhang, Can ; Jin, Hyun Yong...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

Sequential treatment with bendamustine, obinutuzumab (GA101..:

von Tresckow, Julia ; Cramer, Paula ; Robrecht, Sandra...
Leukemia. 36 (2022) 8 - p. 2125-2128 , 2022

Link: https://doi.org/10.1038/..

14

Evaluation of a Prognostic Epigenetic Classification System..:

Grimm, Christina ; Herling, Carmen Diana ; Komnidi, Anastasia...
Biomarker Insights. 17 (2022) - p. 117727192110679 , 2022

Link: https://doi.org/10.1177/..

15

The impact of complex karyotype on the overall survival of ..:

Kreuzer, Karl-Anton ; Furman, Richard R. ; Stilgenbauer, Stephan...
Leukemia. 34 (2019) 1 - p. 296-300 , 2019

Link: https://doi.org/10.1038/..